Routine Use of Intravenous Low-Dose Recombinant Tissue Plasminogen Activator in Japanese Patients

2009149 citationsJournal Articlebronze Open Access

Authors

Ḱazunori Toyoda · Kohnan Hospital

Masatoshi Koga · National Cerebral and Cardiovascular Center

Masaki Naganuma · Jichi Medical University

Yoshiaki Shiokawa · St. Marianna University School of Medicine

Jyoji Nakagawara · National Hospital Organization

Eisuke Furui · Kobe City Medical Center General Hospital

Kazumi Kimura

Abstract

Three-month outcomes of patients receiving low-dose intravenous recombinant tissue plasminogen activator therapy in the present study were similar to those from postmarketing surveys using 0.9 mg/kg alteplase.

Topics & Keywords

Acute Ischemic Stroke Management Cerebrovascular and Carotid Artery Diseases Stroke Rehabilitation and Recovery

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Stroke

Volume 40, Issue 11, pp. 3591-3595

DOI: 10.1161/strokeaha.109.562991

Field-Weighted Citation Impact: 9.45